Screener
Tandem Diabetes Care TNDM Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Sales | $254,560 | $240,678 | $501,781 | $475,100 |
| Cost of sales | 109,780 | 114,823 | 220,213 | 230,838 |
| Gross profit | 144,780 | 125,855 | 281,568 | 244,262 |
| Operating expenses: | ||||
| Selling, general and administrative | 111,642 | 109,596 | 219,829 | 223,449 |
| Research and development | 46,930 | 48,118 | 92,965 | 98,333 |
| Acquired in-process research and development expenses | — | — | — | 75,217 |
| Litigation and settlement expense | — | 19,951 | — | 19,951 |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's total revenue?
- Tandem Diabetes Care (TNDM) reported total revenue of $254.56M in Q2 2026.
- How has Tandem Diabetes Care's total revenue changed year-over-year?
- Tandem Diabetes Care's total revenue increased by 5.8% year-over-year, from $240.68M to $254.56M.
- What is the long-term trend for Tandem Diabetes Care's total revenue?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's total revenue has grown at a 9.6% compound annual growth rate (CAGR), from $702.8M to $1.01B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Tandem Diabetes Care's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude